Learning from hackers: Open-source clinical trials

Science Translational Medicine

Volumn 4, Issue 132, 2012, Pages

  Dunn, Adam G ^a   Day, Richard O ^a   Mandl, Kenneth D ^b,c   Coiera, Enrico ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DATA REPOSITORY; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COMMUNICATION SOFTWARE; COMPUTER PROGRAM; CONFLICT OF INTEREST; DATA ANALYSIS SOFTWARE; DECENTRALIZATION; EVIDENCE BASED MEDICINE; FREEDOM OF INFORMATION ACT; HUMAN; INFORMATION DISSEMINATION; INTELLECTUAL FREEDOM; KNOWLEDGE BASE; MANDATORY PROGRAM; MEDICAL RESEARCH; NONHUMAN; NOTE; ONLINE SYSTEM; PATIENT IDENTIFICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRIVACY; TRANSLATIONAL RESEARCH; ARTICLE; CLINICAL TRIAL (TOPIC); COMPUTER SECURITY; FREEDOM; LEARNING;

CLINICAL TRIALS AS TOPIC; COMPUTER SECURITY; FREEDOM; HUMANS; LEARNING;

EID: 84860761759     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3003682     Document Type: Note

References (37)

1. H. Bastian, P. Glasziou, I. Chalmers, Seventy-five trials and eleven systematic reviews a day: How will we ever keep up? PLoS Med. 7, e1000326 (2010).
2. T. A. Kotchen, Why the slow diff usion of treatment guidelines into clinical practice? Arch. Intern. Med. 167, 2394-2395 (2007).
3. F. Davidoff, J. Miglus, Delivering clinical evidence where it's needed: Building an information system worthy of the profession. JAMA 305, 1906-1907 (2011).
4. K. Dickersin, D. Rennie, Registering clinical trials. JAMA 290, 516-523 (2003).
5. N. Rasmussen, K. Lee, L. Bero, Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials 10, 116 (2009).
6. K. Lutchen, J. Ayers, S. Gallagher, L. Abu-Taleb, Engineering efficient technology transfer. Sci. Transl. Med. 3, 10cm32 (2011).
7. B. H. Munos, W. W. Chin, How to revive breakthrough innovation in the pharmaceutical industry. Sci. Transl. Med. 3, 89cm16 (2011).
8. T. C. Norman, C. Bountra, A. M. Edwards, K. R. Yamamoto, S. H. Friend, Leveraging crowdsourcing to facilitate the discovery of new medicines. Sci. Transl. Med. 3, 88mr1 (2011).
9. S. F. Terry, P. F. Terry, Power to the people: Participant ownership of clinical trial data. Sci. Transl. Med. 3, 69cm3 (2011).
10. I. Chalmers, P. Glasziou, Avoidable waste in the production and reporting of research evidence. Lancet 374, 86-89 (2009).
11. S. Levy, Hackers: Heroes of the Computer Revolution. (Anchor Press/Doubleday, Garden City, New York, 1984), pp. 458.
12. The Free Software Foundation, The Free Software Definition, Accessed 14 July 2011, http://www.gnu.org/philosophy/free-sw.html (1996).
13. J. W. Paulson, G. Succi, A. Eberlein, An empirical study of open-source and closed-source software products. IEEE Trans. Softw. Eng. 30, 246-256 (2004).
14. E. Raymond, The cathedral and the bazaar. Knowl. Tech. Policy 12, 23-49 (1999).
15. R. Iyengar, C. Van den Bulte, T. W. Valente, Opinion leadership and social contagion in new product diff usion. Mark. Sci. 30, 195-212 (2011).
16. A. Bonaccorsi, C. Rossi, Comparing motivations of individual programmers and firms to take part in the open source movement: From community to business. Knowl. Tech. Policy 18, 40-64 (2006).
17. A. G. Dunn, F. T. Bourgeois, S. Murthy, K. D. Mandl, R. O. Day, E. Coiera, The role and impact of research agendas on the comparative-eff ectiveness research among antihyperlipidemics. Clin. Pharmacol. Ther. 91, 685-691 (2012).
18. F. T. Bourgeois, S. Murthy, K. D. Mandl, Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann. Intern. Med. 153, 158-166 (2010).
19. M. D. Cabana, C. S. Rand, N. R. Powe, A. W. Wu, M. H. Wilson, P. A. Abboud, H. R. Rubin, Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282, 1458-1465 (1999).
20. Framingham Heart Study, Framingham Heart Study Bibliography. Accessed 14 July 2011, http://www.framinghamheartstudy.org/biblio/index.html (2011).
21. H. Rohde, J. Qin, Y. Cui, D. Li, N. J. Loman, M. Hentschke, W. Chen, F. Pu, Y. Peng, J. Li, F. Xi, S. Li, Y. Li, Z. Zhang, X. Yang, M. Zhao, P. Wang, Y. Guan, Z. Cen, X. Zhao, M. Christner, R. Kobbe, S. Loos, J. Oh, L. Yang, A. Danchin, G. F. Gao, Y. Song, Y. Li, H. Yang, J. Wang, J. Xu, M. J. Pallen, J. Wang, M. Aepfelbacher, R. Yang, E. coli O104:H4 Genome Analysis Crowd-Sourcing Consortium, Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4. N. Engl. J. Med. 365, 718-724 (2011).
22. C. Baigent, L. Blackwell, J. Emberson, L. E. Holland, C. Reith, N. Bhala, R. Peto, E. H. Barnes, A. Keech, J. Simes, R. Collins, Cholesterol Treatment Trialists' (CTT) Collaboration, Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376, 1670-1681 (2010).
23. D. A. Zarin, T. Tse, R. J. Williams, R. M. Califf, N. C. Ide, The ClinicalTrials.gov results database - Update and key issues. N. Engl. J. Med. 364, 852-860 (2011).
24. E. Coiera, Building a national health IT system from the middle out. J. Am. Med. Inform. Assoc. 16, 271-273 (2009).
25. I. Sim, D. E. Detmer, Beyond trial registration: A global trial bank for clinical trial reporting. PLoS Med. 2, e365 (2005).
26. F. Wood, T. Guinter, Evolution and implementation of the CDISC Study Data Tabulation Model (SDTM). Pharmaceutical Programming 1, 20-27 (2008).
27. D. Estrin, I. Sim, Open mHealth architecture: An engine for health care innovation. Science 330, 759-760 (2010).
28. R. D. Riley, P. C. Lambert, G. Abo-Zaid, Meta-analysis of individual participant data: Rationale, conduct, and reporting. BMJ 340, c221 (2010).
29. A. Mullard, The long Avandia endgame. Lancet 378, 113 (2011).
30. N. H. Goldberg, S. Schneeweiss, M. K. Kowal, J. J. Gagne, Availability of comparative efficacy data at the time of drug approval in the United States. JAMA 305, 1786-1789 (2011).
31. P. C. Gøtzsche, A. W. Jørgensen, Opening up data at the European medicines agency. BMJ 342, d2686 (2011).
32. B. Hanson, A. Sugden, B. Alberts, Making data maximally available. Science 331, 649 (2011).
33. G. Loukides, J. C. Denny, B. Malin, The disclosure of diagnosis codes can breach research participants' privacy. J. Am. Med. Inform. Assoc. 17, 322-327 (2010).
34. J. Lerner, J. Tirole, Some simple economics of open source. J. Ind. Econ. 50, 197-234 (2002).
35. M. S. Boguski, K. D. Mandl, V. P. Sukhatme, Repurposing with a diff erence. Science 324, 1394-1395 (2009).
36. B. H. Munos, W. W. Chin, A call for sharing: Adapting pharmaceutical research to new realities. Sci. Transl. Med. 1, 9cm8 (2009).
37. S. M. Paul, D. S. Mytelka, C. T. Dunwiddie, C. C. Persinger, B. H. Munos, S. R. Lindborg, A. L. Schacht, How to improve R&D productivity: The pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov. 9, 203-214 (2010).